RIXUBIS
NDC 0944-3026, COAGULATION FACTOR IX (RECOMBINANT), kit, from Takeda Pharmaceuticals America, Inc..
- Product NDC
- 0944-3026
- Status
- Listed
- Labeler
- Takeda Pharmaceuticals America, Inc.
- Dosage form
- KIT
- Route
- —
- Product type
- PLASMA DERIVATIVE
- Marketing category
- BLA
- Application
- BLA125446
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0944-3026 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
None listed.
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0944-3026-02 | 00944302602 | 1 KIT in 1 CARTON (0944-3026-02) * 5 mL in 1 VIAL, GLASS (0944-3025-01) * 5 mL in 1 VIAL, GLASS (64764-515-50) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
Medicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=0944-3026
Use it
Look up 0944-3026 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0944-3026 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0944-3026. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.